Role of the epithelial-mesenchymal transition during tumor progression;Rôle de la transition épithéliomésenchymateuse dans la progression tumorale

Bulletin du Cancer

Volumn 97, Issue 1, 2010, Pages 7-15

  Ansieau, S ^a   Caron De Fromentel, C ^a   Bastid, J ^a,b   Morel, A P ^a,c   Puisieux, A ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE LÉON BÉRARD   (France)

Author keywords

Embryogenesis; EMT; Metastatic dissemination; Tumor progression

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; SMAD PROTEIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR TWIST; UVOMORULIN; TRANSCRIPTION FACTOR;

APOPTOSIS; CANCER INHIBITION; CELL MOTILITY; EPITHELIUM CELL; EPITHELIUM TUMOR; MESENCHYME CELL; METASTASIS; REVIEW; TUMOR GROWTH; ANIMAL; ARTICLE; CANCER INVASION; CANCER STEM CELL; CELL AGING; CELL MOTION; CELL TRANSDIFFERENTIATION; DISEASE COURSE; GENETICS; HUMAN; MESODERM; MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL AGING; CELL MOVEMENT; CELL TRANSDIFFERENTIATION; DISEASE PROGRESSION; EPITHELIAL CELLS; HUMANS; MESODERM; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 75749125815     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.1025     Document Type: Article

References (59)

1. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009 ; 1796 : 293-308.
2. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and darwinian selection in tumors. Trends Cell Biol 1999 ; 9 : M57-M60.
3. Thiery JP. Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2002 ; 2 : 442-54.
4. Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008 ; 14 : 818-29.
5. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002 ; 110 : 341-50.
6. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008 ; 68 : 3645-54.
7. Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004 ; 117 : 927-39.
8. Puisieux A, Valsesia-Wittmann S, Ansieau S. A twist for survival and cancer progression. Br J Cancer 2006 ; 94 : 13-7.
9. DumontN,WilsonMB, Crawford YG, Reynolds PA, SigaroudiniaM, Tlsty TD. Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers. Proc Natl Acad Sci USA 2008 ; 105 : 14867-72.
10. Peinado H, Olmeda D, Cano A. SNAI1, ZEB and bHLH factors in tumor progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007 ; 7 : 415-28.
11. Desprat N, Supatto W, Pouille PA, Beaurepaire E, Farge E. Tissue deformation modulates twist expression to determine anterior midgut differentiation in drosophila embryos. Dev Cell 2008 ; 15 : 470-7.
12. Farge E. Mechanical induction of twist in the drosophila foregut/ stomodeal primordium. Curr Biol 2003 ; 13 : 1365-77.
13. Gort EH, van HG, Verlaan I, Groot AJ, Plasterk RH, Shvarts A, et al. The twist1 oncogene is a direct target of hypoxia-inducible factor-2-alpha. Oncogene 2008 ; 27 : 1501-10.
14. Evans AJ, Russell RC, Roche O, Burry TN, Fish JE, Chow VW, et al. VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and SNAI1. Mol Cell Biol 2007 ; 27 : 157-69.
15. Straseski JA, Gibson AL, Thomas-Virnig CL, Len-Hoffmann BL. Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen. Wound Repair Regen 2009 ; 17 : 606-16.
16. Firulli AB, Conway SJ. Phosphoregulation of twist1 provides a mechanism of cell fate control. Curr Med Chem 2008 ; 15 : 2641-7.
17. Peinado H, Portillo F, Cano A. Switching on-off SNAI1: LOXL2 versus GSK3-beta. Cell Cycle 2005 ; 4 : 1749-52.
18. Demontis S, Rigo C, Piccinin S, Mizzau M, Sonego M, Fabris M, et al. twist is substrate for caspase cleavage and proteasomemediated degradation. Cell Death Differ 2006 ; 13 : 335-45.
19. Wu Y, Deng J, Rychahou PG, Qiu S, Evers BM, Zhou BP. Stabilization of SNAI1 by NF-kappaB is required for inflammationinduced cell migration and invasion. Cancer Cell 2009 ; 15 : 416-28.
20. Billottet C, Jouanneau J. Tumor-stroma interactions. Bull Cancer 2008 ; 95 : 51-6.
21. Ao M, Williams K, Bhowmick NA, Hayward SW. Transforming growth factor-beta promotes invasion in tumorigenic but not in nontumorigenic human prostatic epithelial cells. Cancer Res 2006 ; 66 : 8007-16.
22. Spaderna S, Schmalhofer O, Hlubek F, Berx G, Eger A, Merkel S, et al. A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology 2006 ; 131 : 830-40.
23. Rees JR, Onwuegbusi BA, Save VE, Alderson D, Fitzgerald RC. In vivo and in vitro evidence for transforming growth factorbeta1-mediated epithelial to mesenchymal transition in esophageal adenocarcinoma. Cancer Res 2006 ; 66 : 9583-90.
24. Fendrich V, Waldmann J, Esni F, Ramaswamy A, Mullendore M, Buchholz M, et al. SNAI1 and Sonic Hedgehog activation in neuroendocrine tumors of the ileum. Endocr Relat Cancer 2007 ; 14 : 865-74.
25. Kaihara T, Kusaka T, Nishi M, Kawamata H, Imura J, Kitajima K, et al. Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis. J Exp Clin Cancer Res 2003 ; 22 : 117-23.
26. Hirata T, Fukuse T, Naiki H, Wada H. Expression of E-cadherin and lymph node metastasis in resected non-small cell lung cancer. Clin Lung Cancer 2001 ; 3 : 134-40.
27. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, et al. Expression of E-cadherin cell adhesionmolecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 1993 ; 53 : 1696-701.
28. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005 ; 65 : 5996-6000.
29. Davies JA. Mesenchyme to epithelium transition during development of the mammalian kidney tubule. Acta Anat (Basel) 1996 ; 156 : 187-201.
30. Hosono S, Luo X, Hyink DP, Schnapp LM,Wilson PD, Burrow CR, et al. WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene 1999 ; 18 : 417-27.
31. Trimboli AJ, Fukino K, de Bruin A, Wei G, Shen L, Tanner SM, et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res 2008 ; 68 : 937-45.
32. Valsesia-Wittmann S, Magdeleine M, Dupasquier S, Garin E, Jallas AC, Combaret V, et al. Oncogenic cooperation between H-twist and N-myc overrides failsafe programs in cancer cells. Cancer Cell 2004 ; 6 : 625-30.
33. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, et al. Induction of EMT by twist proteins as a collateral effect of tumorpromoting inactivation of premature senescence. Cancer Cell 2008 ; 14 : 79-89.
34. Puisieux A, Valsesia-Wittmann S. Cancer cells escape from fail safe programs in a simple twist. Bull Cancer 2006 ; 93 : 251-6.
35. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008 ; 13 : 58-68.
36. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ, et al. The transcriptional repressor SNAI1 promotes mammary tumor recurrence. Cancer Cell 2005 ; 8 : 197-209.
37. Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during SNAI1-induced EMT of cancer cells. Cancer Cell 2009 ; 15 : 195-206.
38. Arima Y, Inoue Y, Shibata T, Hayashi H, Nagano O, Saya H, et al. RB depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition. Cancer Res 2008 ; 68 : 5104-12.
39. Debies MT, Gestl SA, Mathers JL, Mikse OR, Leonard TL, Moody SE, et al. Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19ARF/p53 pathway lesions but not p16 Ink4a loss. J Clin Invest 2008 ; 118 : 51-63.
40. Krizhanovsky V, Lowe SW. Stem cells: the promises and perils of p53. Nature 2009 ; 460 : 1085-6.
41. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelialmesenchymal transition. PLoS ONE 2008 ; 3 : e2888.
42. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008 ; 133 : 704-15.
43. Al-Hajj M, Wicha MS, Ito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003 ; 100 : 3983-8.
44. Larsen CJ. Stem cells and cancer: the last frontier? Bull Cancer 2006 ; 93 : 1083-4.
45. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells -an integrated concept of malignant tumor progression. Nat Rev Cancer 2005 ; 5 : 744-9.
46. Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 2009 ; 106 : 13820-5.
47. Wang X, Ling MT, Guan XY, Tsao SW, Cheung HW, Lee DT, et al. Identification of a novel function of twist, a bHLH protein, in the development of acquired taxol resistance in human cancer cells. Oncogene 2004 ; 23 : 474-82.
48. Kajiyama H, Shibata K, Terauchi M, Yamashita M, Ino K, Nawa A, et al. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int J Oncol 2007 ; 31 : 277-83.
49. Wang Z, Li Y, Kong D, Banerjee S, Ahmad A, Azmi AS, et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 2009 ; 69 : 2400-7.
50. Yang AD, Fan F, Camp ER, Van BG, Liu W, Somcio R, et al. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res 2006 ; 12 : 4147-53.
51. Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, et al. twist is a potential oncogene that inhibits apoptosis. Genes Dev 1999 ; 13 : 2207-17.
52. Kwok WK, Ling MT, Yuen HF, Wong YC, Wang X. Role of p14ARF in twist-mediated senescence in prostate epithelial cells. Carcinogenesis 2007 ; 28 : 2467-75.
53. Zhuo W, Wang Y, Zhuo X, Zhang Y, Ao X, Chen Z. Knockdown of SNAI1, a novel zinc finger transcription factor, via RNA interference increases A549 cell sensitivity to cisplatin via JNK/mitochondrial pathway. Lung Cancer 2008 ; 62 : 8-14.
54. Perez-Mancera PA, Perez-Caro M, Gonzalez-Herrero I, Flores T, Orfao A, de Herreros AG, et al. Cancer development induced by graded expression of SNAI1 in mice. Hum Mol Genet 2005 ; 14 : 3449-61.
55. Perez-Mancera PA, Gonzalez-Herrero I, Perez-Caro M, Gutierrez-Cianca N, Flores T, Gutierrez-Adan A, et al. SLUG in cancer development. Oncogene 2005 ; 24 : 3073-82.
56. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, et al. Senescence and tumor clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007 ; 445 : 656-60.
57. Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, et al. Restoration of p53 function leads to tumor regression in vivo. Nature 2007 ; 445 : 661-5.
58. Harney AS, Lee J, Manus LM, Wang P, Ballweg DM, LaBonne C, et al. Targeted inhibition of SNAI1 family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate. Proc Natl Acad Sci USA 2009 ; 106 : 13667-72.
59. Gupta PB,Onder TT, JiangG, Tao K, Kuperwasser C,Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by highthroughput screening. Cell 2009 ; 138 : 645-59.